Sale!

RAPSN Gene Myasthenic Syndrome Congenital Type 11 Associated with Acetylcholine Receptor Deficiency Genetic Test

Original price was: $700.Current price is: $500.

-29%

The RAPSN Gene Myasthenic Syndrome Congenital Type 11 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the RAPSN gene responsible for congenital myasthenic syndrome type 11. This specialized test detects acetylcholine receptor deficiency disorders through advanced next-generation sequencing technology. Patients experiencing muscle weakness, fatigue, breathing difficulties, or feeding problems in infancy should consider this test. The test provides crucial information for accurate diagnosis, personalized treatment strategies, and genetic counseling. Available for $500 USD, this test helps neurologists and genetic specialists develop targeted interventions for improved patient outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

RAPSN Gene Myasthenic Syndrome Congenital Type 11 Associated with Acetylcholine Receptor Deficiency NGS Genetic DNA Test

Understanding RAPSN Gene Myasthenic Syndrome Type 11

RAPSN Gene Myasthenic Syndrome Congenital Type 11 is a rare inherited neuromuscular disorder characterized by impaired transmission at the neuromuscular junction. This condition specifically involves mutations in the RAPSN gene, which plays a critical role in clustering acetylcholine receptors at the postsynaptic membrane. When these receptors are deficient or dysfunctional, proper communication between nerves and muscles is disrupted, leading to the characteristic symptoms of myasthenic syndrome.

What This Advanced Genetic Test Detects

Our comprehensive NGS (Next-Generation Sequencing) genetic DNA test specifically targets and analyzes the RAPSN gene to identify pathogenic variants associated with congenital myasthenic syndrome type 11. The test examines:

  • Complete coding regions of the RAPSN gene
  • Exon-intron boundaries for splicing mutations
  • Known pathogenic variants linked to acetylcholine receptor deficiency
  • Novel mutations that may impact protein function
  • Genetic markers associated with disease severity and progression

Who Should Consider This Genetic Test?

This specialized genetic test is recommended for individuals presenting with symptoms suggestive of congenital myasthenic disorders, including:

  • Infants and children with unexplained muscle weakness
  • Patients experiencing progressive muscle fatigue with activity
  • Individuals with feeding difficulties or swallowing problems in infancy
  • Those with respiratory distress or breathing difficulties
  • Patients with delayed motor milestones development
  • Individuals with a family history of neuromuscular disorders
  • Patients with suspected congenital myasthenic syndromes

Clinical Benefits of RAPSN Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out RAPSN-related congenital myasthenic syndrome
  • Personalized Treatment: Enables targeted therapeutic interventions based on genetic findings
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Prognostic Information: Helps predict disease course and potential complications
  • Therapeutic Guidance: Informs medication choices and management strategies
  • Early Intervention: Facilitates timely treatment to prevent disease progression

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of board-certified genetic specialists and neurologists. Results typically fall into one of these categories:

  • Positive Result: Identifies a pathogenic mutation in the RAPSN gene, confirming the diagnosis of congenital myasthenic syndrome type 11
  • Negative Result: No disease-causing mutations detected in the RAPSN gene, suggesting other potential causes for symptoms
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
  • Carrier Status: Identifies individuals who carry one copy of a mutated gene but may not show symptoms

All results include comprehensive genetic counseling to help you understand the implications and next steps.

Test Pricing and Availability

Test Name Discount Price Regular Price
RAPSN Gene Myasthenic Syndrome Congenital Type 11 NGS Genetic DNA Test $500 USD $700 USD

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.

Take the Next Step Toward Diagnosis

If you or your loved one is experiencing symptoms suggestive of congenital myasthenic syndrome, don’t delay in seeking proper diagnosis. Our comprehensive RAPSN genetic testing provides the clarity needed for effective treatment planning and improved quality of life.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or book your test online. Our genetic counselors and neurological specialists are ready to assist you with personalized care and expert guidance.